AZD9291 US Expanded Access Program
NCT02451852
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
EGFR T790M Mutation Positive NSCLC
Interventions
DRUG:
AZD9291
Sponsor
AstraZeneca